Phreesia delivered solid financial performance in Q3 2026 with a return to positive net income, increased revenue, and improved adjusted EBITDA, supported by growth in healthcare client count and revenue per client.

Phreesia delivered strong results in Q2 2026 with its first quarter of GAAP profitability, a 239% YoY surge in adjusted EBITDA, and continued growth in its healthcare client base and revenue per client.

Phreesia reported a strong start to fiscal year 2026 with significant revenue growth, improved net loss, and a substantial increase in Adjusted EBITDA compared to the prior year.

Phreesia Inc. delivered strong revenue growth of 15% year-over-year in Q4 2025, reaching $109.7 million. The company significantly reduced its net loss to $6.4 million, compared to $30.6 million in the same period last year. Adjusted EBITDA turned positive at $16.4 million, reflecting improved operational efficiency and cost management. The company continues to grow its client base and expand revenue per healthcare services client.

Phreesia announced its Q3 Fiscal Year 2025 results, with total revenue up 17% year-over-year. The company narrowed its revenue outlook for fiscal 2025 to a range of $418 million to $420 million and updated its Adjusted EBITDA outlook for fiscal 2025 to a range of $34 million to $36 million.

Phreesia announced its Q2 Fiscal Year 2025 results, highlighting a 19% year-over-year increase in total revenue to $102.1 million and the achievement of positive free cash flow. The company is maintaining its revenue outlook for fiscal 2025 and updating its Adjusted EBITDA outlook.

Phreesia reported a 21% year-over-year increase in total revenue, reaching $101.2 million. The net loss decreased significantly to $19.7 million, and Adjusted EBITDA was $4.1 million. The company updated its fiscal year 2025 revenue outlook to $416 million to $426 million and Adjusted EBITDA outlook to $21 million to $26 million.

Phreesia announced its Q4 Fiscal Year 2024 results, with total revenue reaching $95.0 million, a 24% increase year-over-year. The company facilitated over 150 million patient visits in fiscal 2024 and is focusing on continued growth and a return to profitability.

Phreesia reported a 25% increase in total revenue, reaching $91.6 million compared to the same period last year. The average number of healthcare services clients increased by 24% to 3,688. Net loss was $31.9 million, an improvement from the $40.2 million loss in the prior year, and adjusted EBITDA was negative $6.6 million, compared to negative $18.3 million in the prior year.

Phreesia announced its Q2 fiscal year 2024 results, with total revenue increasing by 26% to $85.8 million compared to the same period in the prior year. The average number of healthcare services clients increased by 24% to 3,445. Net loss was $36.8 million, and adjusted EBITDA was negative $11.5 million.

Phreesia's total revenue was $83.8 million, a 32% increase compared to the same period last year. The average number of healthcare services clients increased by 31%, while net loss decreased from $51.2 million to $37.5 million.

Phreesia's Q4 2023 saw a 32% increase in revenue year-over-year, reaching $76.6 million. However, the company experienced a net loss of $38.0 million, though an improvement from the previous year's $46.5 million. The average number of healthcare services clients increased by 36% year-over-year.

Phreesia, Inc. reported a revenue of $73.1 million for the third quarter of fiscal year 2023, representing a 31% increase compared to the same period in the prior year. The average number of healthcare services clients increased by 42% to 2,982, while the average revenue per healthcare services client decreased by 9% to $17,645. The company's net loss was $40.2 million, and adjusted EBITDA was negative $18.3 million. Cash and cash equivalents totaled $209.6 million as of October 31, 2022.

Phreesia announced strong second quarter fiscal year 2023 results, with revenue increasing 33% to $67.9 million and the average number of healthcare services clients growing by 40% to 2,776. The company updated its revenue outlook for fiscal year 2023 to a range of $273 million to $275 million and raised its Adjusted EBITDA outlook to a range of negative $109 million to negative $106 million.

Phreesia reported a strong start to fiscal year 2023, with a 31% increase in revenue compared to the same period last year. The company saw gains in new clients and expansion within existing clients across healthcare services and life sciences. The company is maintaining its revenue outlook for fiscal 2023 of $271 million to $275 million implying year-over-year growth of 27% to 29%.

Phreesia's Q4 revenue was $58.0 million, up 39% year-over-year. The average number of healthcare services clients was 2,311, a 28% increase year-over-year, with average revenue per client at $18,430, up 3% year-over-year. Adjusted EBITDA was negative $30.5 million, and cash and cash equivalents totaled $313.8 million.

Phreesia announced its Fiscal Third Quarter 2022 results, reporting a 45% increase in revenue compared to the same period in the prior year. The company surpassed 100 million patient visits enabled by their platform during the previous twelve months. They are increasing their revenue outlook for fiscal year 2022 to $211 million.

Phreesia reported a revenue of $51.0 million for the quarter, a 46% increase compared to the same period in the prior year. The average number of provider clients increased by 19% to 1,987, and the average revenue per provider client grew by 14% to $19,720. Adjusted EBITDA was negative $11.0 million, and cash and cash equivalents reached $439.9 million.

Phreesia reported a 27% increase in revenue for the quarter, reaching $41.8 million. The average number of provider clients grew by 13% year-over-year, and the average revenue per provider client increased by 7%.

Phreesia reported revenue of $38.5 million for the fiscal third quarter ended October 31, 2020, representing a 17% increase compared to the same period in the prior year. The average number of provider clients increased by 10% to 1,737, and the average revenue per provider client increased by 5% to $17,490. Adjusted EBITDA was positive $1.2 million. Cash and cash equivalents totaled $254.1 million.

Phreesia announced its fiscal second quarter 2021 results, reporting a revenue increase of 14% year-over-year. The company's average number of provider clients also increased by 7%, and adjusted EBITDA was positive at $1.2 million.

Phreesia announced its fiscal first quarter 2021 results with a revenue of $33.4 million, an 18% increase compared to the same period last year. The average number of provider clients was 1,632, a 5% increase, and the average revenue per provider client was $16,735, a 7% increase. Adjusted EBITDA was positive at $1.5 million.

Phreesia reported a revenue of $32.8 million for the quarter, representing a 24% increase compared to the same period in the prior year. The average number of provider clients was 1,603, a 4% increase year-over-year, and the average revenue per provider client increased by 18% to $16,708. Adjusted EBITDA was $1.3 million for the quarter.